Forlong Biotechnology
Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer
$17.5MPre-Series B
Role not disclosedActivity from announced rounds
Clinical-stage biotech developing cytokine therapies including IL-15 and IL-18 programs for cancer